Amiloidózis: nyitott vizsgálatok itt: Ausztria
10 trials · From ClinicalTrials.gov, checked 2026. nov. 10.. Ask the study team whether a trial fits you.
3. fázisToborozTrial-stage medicine
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Where
- Innsbruck, St. Poelten, Vienna
- Age
- 18 év to 90 év
- People
- 1200 worldwide
- Run by
- Intellia Therapeutics
See details and how to joinNCT06128629EU 2023-507220-23-00Regiszter frissítve: 2026-11-04
No phaseToborzás még nem indultResearch participation
Single-arm, Multi-center Study Evaluating the Acceptance and Feasibility of a Digital Remote Monitoring Tool Configured for Patients With ATTR-CM: ACO-Monitor
- Where
- Innsbruck
- Age
- 18 év and over
- People
- 60 worldwide
- Run by
- Bayer
See details and how to joinNCT07557147Regiszter frissítve: 2026-10-26
3. fázisCsak meghívásosTrial-stage medicine
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Where
- Vienna
- Age
- 18 év and over
- People
- 700 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT06679946Regiszter frissítve: 2026-10-21
3. fázisToborozTrial-stage medicine
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Where
- Braunau Am Inn, Graz, Vienna, Wels
- Age
- 18 év to 85 év
- People
- 1750 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07052903EU 2024-519917-72-00Regiszter frissítve: 2026-10-20
No phaseToborozResearch participation
Edge-to-edge Mitral Valve Repair in ATTR-CM
- Where
- Graz, Linz, Sankt Pölten, Vienna
- Age
- 18 év and over
- People
- 106 worldwide
- Run by
- Medical University of Vienna
See details and how to joinNCT06075823Regiszter frissítve: 2026-10-16
4. fázisToborozTrial-stage medicine
A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis
- Where
- Braunau am Inn, Feldkirch, Sankt Pölten, Vienna
- Age
- 18 év to 90 év
- People
- 50 worldwide
- Run by
- Bayer
See details and how to joinNCT07298044EU 2025-521831-35-00Regiszter frissítve: 2026-10-15
No phaseToborozResearch participation
A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
- Where
- Multiple Locations
- Age
- 18 év and over
- People
- 2000 worldwide
- Run by
- Bayer
See details and how to joinNCT07235462Regiszter frissítve: 2026-10-08
3. fázisToborzás még nem indultTrial-stage medicine
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
- Where
- Graz, Innsbruck, Vienna, Wels
- People
- 1180 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07789483EU 2026-526755-57-00Regiszter frissítve: 2026-08-28
3. fázisCsak meghívásosTrial-stage medicine
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
- Where
- Graz, Innsbruck, Vienna
- Age
- 18 év and over
- People
- 1400 worldwide
- Run by
- Ionis Pharmaceuticals, Inc.
See details and how to joinNCT05667493Regiszter frissítve: 2026-04-17
No phaseToborozResearch participation
A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.
- Where
- Graz, Vienna
- Age
- 18 év and over
- People
- 600 worldwide
- Run by
- Medical University of Vienna
See details and how to joinNCT06836011Regiszter frissítve: 2025-02-19
Minden vizsgálat (Amiloidózis) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.